---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-022668"
form_type: "8-K"
ticker: "ZVRA"
cik: "0001434647"
company_name: "ZEVRA THERAPEUTICS, INC."
filed_at: "2024-07-12T23:59:59+00:00"
generated_at: "2026-05-31T21:03:56.989347+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Zevra Therapeutics enters $75M at-the-market equity distribution agreement with Citizens JMP Securities

## Summary
- ATM facility allows sale of up to $75M in common stock at company's discretion.
- Sales agent receives 3% commission on gross proceeds; shares sold under existing shelf registration.
- Prior equity distribution agreement with Citizens JMP and RBC Capital terminated effective July 12, 2024.
- Company is not obligated to make any sales under the new agreement.

## SEC filing metadata
- accession: 0001437749-24-022668
- form_type: 8-K
- ticker: ZVRA
- cik: 0001434647
- company_name: ZEVRA THERAPEUTICS, INC.
- filed_at: 2024-07-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1434647/000143774924022668/0001437749-24-022668-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1434647/000143774924022668/zvra20240711_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-022668
- JSON: https://secwatch.observer/filing/0001437749-24-022668.json
- Plain text: https://secwatch.observer/filing/0001437749-24-022668.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.